A股異動 | 延江股份漲停 醫用熔噴無紡布已收到約55家客户的訂單
格隆匯4月7日丨延江股份(300658.SZ)漲停,現報29.24元,暫成交2.83億元,最新總市值44億元。延江股份上週五(3日)晚間發公告稱,公司的醫用熔噴無紡布已經完成第三方檢測以及公司內部的商業化生產測試,產品銷售工作正式展開,截至公告日,已收到約55家客户的訂單。公司將根據訂單的要求,調整熔噴無紡布的生產、銷售計劃,現階段尚無法準確量化其對公司的影響,但相關金額預計將大於公司最近一個會計年度經審計淨利潤的40%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.